Theme: Rising helpful advances in cancer sorts
Cancer Middle East 2015
OMICS International provides an opportunistic environment and vibrant podium through these auspicious events to amplify these steps and meet the highest demand ever, by reflexive and cerebrative connections. Established in the year 2007, OMICS Group International has been progressively organizing scientific conferences across the globe, rendezvous which consist of various streams of scientific study to improve and accelerate discovery for a better tomorrow. The non-profit firm plans for organizing an average of 1000 international conferences per year which is supported by 700 open access journals and 80,000 Editorial Board Members. The number of reader views of the website has clocked 7.5 million and still counting. Lately around more than 1000 scientific associations of various fields from all over the world have shown interest in association with OMICS Group International to promote their research work. OMICS International conferences offer exciting features like international symposia, B2B meetings, trade shows, exhibitions, and international workshops to build global networking and meaningful academic research and industry alliances. OMICS initiated the 'Young Scientist awards' to the enterprising young science researchers and scholars across the globe. OMICS International conferences also organize Cancer Conferences.
Cancer Middle East 2015 is an extraordinary event designed for International medical health professionals and oncologists to facilitate the dissemination and application of research findings related to Cancer. The conference invites participants from all leading universities, clinical research institutions and diagnostic companies to share their research experiences on all aspects of this rapidly expanding field and thereby, providing a showcase of the latest techniques.
Cancer Cell Biology, Diagnosis and Applied Research are using cell biological and other methods to investigate the mechanisms that regulate cell proliferation and differentiation. Cancer is a multistep process involving several cell signaling pathways. Membrane proteins are involved in the prognosis of the most common forms of cancer. Membrane proteins are the hallmark of a cancer cell. These overexpressed membrane receptors are becoming increasingly important in cancer cell therapy. There are hundreds of people affected by cancer who are willing to share their story, give an opinion, a quote, or a full interview. OMICS International delighted to organize conference related to this topic i.e. Ulcerative colitis conference which deals with Ulcerative colitis which is a form of inflammatory bowel disease that causes inflammation and ulcers in the colon. . OMICS International delighted to organize Anorexia events related to Anorexia nervosa which is an eating disorder characterized by a low weight, fear of gaining weight, a strong desire to be thin, and food restriction. Parafollicular events deal with Parafollicular cells in the thyroid which primary function is to secrete calcitonin. They are located adjacent to the thyroid follicles and reside in the connective tissue.
Organ Specific Cancers are cancers named basing on the location of cancer in the body organ. Cancer can affect just about every organ in the human body. Each type of cancer is unique with its own causes, symptoms, and methods of treatment. Lung cancer was the most common cancer worldwide in men contributing nearly 17% of the total number of new cases diagnosed in 2012 and became an important topic for World Cancer Conferences. There are more than 200 different types of cancer, but Breast cancer, Head & Neck Cancer, Blood, lung and leukemia cancer cancers that are diagnosed with the greatest frequency. Lung cancer, also known as carcinoma of the lung or pulmonary carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. The Lung Cancer Conference is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies. Cancer genetics is now one of the fastest expanding medical specialties. However, some people inherit mutation in the germ line. The mutations occur in two classes of cellular genes: oncogenes and tumor suppressor genes. Breast cancer is the most common type of cancer among women in Arab so it is a very important topic for Cancer Conferences Dubai.
Malignancy is most familiar as a characterization of cancer. A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Small molecules are usually designed to interfere with the enzymatic activity of the target protein. Carcinoids conferences include the research related to Carcinoids that are rare tumour which tend to be slow growing. They may not cause any symptoms for several years. Most of this tumour occurs in people over the age of 60. New anticancer agents are exploiting this vulnerability of cancer cells to enhance therapeutic indexes, with limited normal tissue toxicity. Due to the numerous roles of p53 in genomic stability and its defects in many human cancers, therapeutic agents that restore p53 activity in tumors are the subject of multiple clinical trials. In many cancers studied thus far, a small population of cells called cancer stem cells self-renew to replenish the growing cancer. In order to eliminate the disease, it is these cells that chemotherapy must wipe out. Breast Cancer Conference includes the advances have been largely achieved through the successful application of a multidisciplinary approach in the treatment and care of breast cancer. The study of cancer epidemiology uses epidemiological methods to find the cause of cancer and to identify and develop improved treatments.
Anti-cancer monoclonal antibodies can be targeted against malignant cells by several mechanisms. Tissue-specific gene delivery using immune liposomes has also been achieved in brain, and breast cancer tissue. A cancer vaccine is a vaccine that either treats existing cancer or prevents development of a cancer. Vaccines that treat existing cancer are known as therapeutic cancer vaccines. There are currently no vaccines able to prevent all cancers. Treatment often fails when cancer becomes resistant to anti-cancer drugs. Thus, drug resistance is a big challenge facing the survival of cancer patients. Research in discovering and designing drugs with new chemistry structure or mechanism of action is critical to overcome the drug resistance problem and give patient better chance to survive longer. The use of nanotechnology in cancer treatment offers some exciting possibilities, including the possibility of destroying cancer tumors with minimal damage to healthy tissue and organs, as well as the detection and elimination of cancer cells before they form tumors. Knowledge of all the human genes and their functions may allow effective preventive measures, and change drug research strategy and drug discovery development processes. The Oncology Conference delivers practical ideas, solutions, and strategies to implement in cancer program today.
Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer. Despite the fact that new technologies and strategies often fail to identify well-established cancer biomarkers and show a bias toward the identification of high-abundance molecules, these technological advances have the capacity to revolutionize biomarker discovery. The study of the tumor metabolism describes the different characteristic metabolic changes in tumor cells. The emerging field of metabolomics – which attempts to profile all metabolites within a cell or biological system – is now being used to analyze cancer metabolism on a system-wide scale, painting a broad picture of the altered pathways and their interactions with each other. While a large fraction of cancer metabolomics research is focused on finding diagnostic biomarkers, metabolomics is also being used to obtain more fundamental mechanistic insight into cancer and carcinogenesis. OMICS is delighted to organize radiation oncology conference in upcoming year which discuss about radiation techniques.
Anti-carcinogens are different from anti-carcinoma agents in that anti-carcinoma agents are used to selectively destroy or inhibit cancer cells after cancer has developed. Advances in analytical methods and recombinant DNA technology contributed greatly to the study of metabolism of chemical carcinogens. Major advances have been made in the assignment of roles of individual enzymes in reactions. Clinical research is a branch of healthcare science that determines the safety and effectiveness of medications, devices, diagnostic products and treatment regimens intended for human use. Cancer research is basic research into cancer in order to identify causes and develop strategies for prevention, diagnosis, treatments and cure. Carcinogenesis is the actual formation of a cancer, whereby normal cells are transformed into cancer cells. The main carcinogenic factors can be grouped into: primary determining factors; secondary determining factors; favoring factors. Different types of non-ionizing and ionizing radiations are major factors in the mechanisms of carcinogenesis. Chemical carcinogenic substances are first activated through the hepatic microsomal system, and then they bind in a covalent form to the macromolecules (DNA, RNA, proteins) from the target organs. Surgical oncology conferences are the upcoming conferences of OMICS discusses about the treating cancer through surgery.
Experimental cancer treatments are medical therapies intended or claimed to treat cancer by improving on, supplementing or replacing conventional methods (surgery, chemotherapy, radiation, and immunotherapy). Oncolytic virotherapy is an exciting, increasingly recognized discipline in cancer research. The recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Oncology Conferences 2015 deal with molecular medicine, drug therapy blocks the growth of cancer cells by interfering with specific targeted molecules needed for carcinogenesis and tumor growth, rather than by simply interfering with all rapidly dividing cells (traditional chemotherapy). Oncology meetings 2015, providing medical oncologists with an ideal platform to network with pharmaceutical partners and a dedicated opportunity to gain further insight into tangible advances in the treatment of cancer. Sievert events deal with the sievert is a derived unit of ionizing radiation dose in the International System of Units (SI). It is a measure of the health effect of low levels of ionizing radiation on the human body. Quantities that are measured in sieverts are intended to represent the stochastic health risk, which for radiation dose assessment is defined as the probability of cancer induction and genetic damage.
Cancer survival rates or survival statistics tell you the percentage of people who survive a certain type of cancer for a specific amount of time. Cancer statistics often use an overall five-year survival rate. Cancer survival rates are supported on research from information gathered on hundreds or thousands of individual with a particular cancer. An overall survival rate includes individuals of all ages and health conditions who have been diagnosed together with your cancer, together with those diagnosed terribly early and people diagnosed terribly late. Kaposis sarcoma events which about Kaposi's sarcoma is a tumor caused by infection with human herpes virus 8 (HHV8), also known as Kaposi's sarcoma-associated herpes virus (KSHV) or KS agent. Cancer Middle East-2015 focuses on recent advances in skin carcinoma diagnosis and treatment which is a best opportunity to have a perfect research gathering.
European Oncology Conference help researchers learn more about cancer, they’re developing new therapies that target particular types of tumor cells and restrict their growth. On their own or in combination with other alternative treatments, these therapies can decrease the size of tumors and symptoms. Some innovative therapies give hope for people with cancers that have been resistant to more treatments. There are different stages of the cancer like Stage 1, Stage 2, Stage 3 and Stage 4. Translation cell carcinoma is an implication of translational techniques for cancer treatment where new treatments can be developed.
Ayurvedic medicine will focus on advice on diet and special diets, Taking specific Ayurvedic medications, Herbal medicine, Massage, Meditation, Yoga and Breathing and relaxation techniques. People with cancer usually prefer touch therapies such as massage and aromatherapy. Blood carcinoma is one of the major cancer that affect mainly blood, bone marrow, lymph and lymphatic system for treating this recent techniques have been discovered by the researchers through targeting the tumor and restrict their growth. A larger section of individuals say these therapies help them to cope better with cancer and its treatment. Research is looking into whether some herbs or plant treatments used in Ayurvedic medicine can prevent or treat cancer. Oncology Nursing conferences is the upcoming conference in which nursing techniques are been discussed as there are limited educational program in oncology nursing this will be the best platform to share ideas. Some herbal treatments may affect the way cancer drugs are broken down by the human body or the way drugs are transported around human body.
Lung cancer or Pulmonary Carcinoma is the one of the most common cancers we generally see, which will be accounting for about one out of five cases in men and one out of nine in women and a very important topic for American Society Oncology Conference as Lung cancer is the leading cancer killer in both men and women in the United States. In 1987, it surpassed breast cancer to become the leading cause of cancer deaths in women. Lung cancer causes more deaths than colorectal, breast and prostate cancers combined. An estimated 158,040 Americans are expected to die from lung cancer in 2015, accounting for approximately 27 percent of all cancer deaths. Unfortunately, over the past years, while the incidence of lung cancer has gradually decreased in men, it has been rising dangerously in women.
There are two types of lung cancer: Small cell lung cancer, which is also called oat cell cancer, why because the cells looks like oat grains and non-small cell lung cancer. The aggressiveness of the disease and treatment options will be depending on the type of tumor recognized.
Carcinoma is a type of cancer which will be developed from epithelial cells. Especially, a carcinoma is a cancer which begins in a tissue that lines the inner or outer surfaces of the body, and that generally arises from cells in the endodermal or ectodermal germ layer during embryogenesis. Cancer affects when a single progenitor cell accumulates mutations and changes in the DNA, histones, and other biochemical compounds which make the cell's genome. The cell genome regulates the structure of the cell's biochemical components, the biochemical reactions that generally occur within the cell, and the biological interactions of that cell with other cells. Osteosarcoma conferences deal with an osteosarcoma which is a cancerous tumor in bone. Osteosarcoma is the most common histological form of primary bone cancer. It is most prevalent in children and young adults.
The financial costs of cancer are very high for both the person with cancer and for society as a total. The Agency for Healthcare research and Quality (AHRQ) estimates that the direct medical costs (total of all health care costs) for cancer in the US in 2011 were $88.7 billion. And according to Cancer Facts & Figures 2015, “Uninsured patients and those from ethnic minorities are substantially more likely to be diagnosed with cancer at a later stage, when treatment can be more extensive, more costly, and less successful.” The Oncology exhibitions are the best platform to exhibit oncology related products.
Middle east Cancer summits are extraordinary event for middleeast countries as the incidence of cancer in the Middle East is expected to increase more than in any other part of the world, doubling in the next ten years. The Western lifestyle and diet, more young people smoking, obesity, a high prevalence of hepatitis C infection, and industrial and agricultural pollution, have all been linked as contributing factors to this worrying trend. In Jordan, Egypt, Syria and Sudan, more than 65% of breast cancer cases are detected at advanced stages, by which time the patient is usually inoperable (Read: Fighting a growing enemy). But even if screening program continues to improve, actual access to the best medications is another barrier to overcome, one that is set higher in North African countries compared to the Gulf. So it is very crucial to organize Cancer Conferences Middle east which help to advances cancer screening programs for early detection.
Many Oncology events give a general but in-depth update about the major topics in medical oncology. Cryosurgery is the surgery using the local application of intense cold to destroy unwanted tissue. Halaven events is about HALAVEN which is a prescription medicine used to treat patients with metastatic breast cancer. HALAVEN is for patients who have already received at least 2 other types of anticancer medicines for their breast cancer once it has spread to other parts of the body. Radiosensitizer events are uplifting, inspiring and great at bringing the fight against cancer directly into our community.
7th Global Summit on Cancer Therapy (Cancer Middle East 2015)
October 05-07, 2015 Dubai, UAE
(Theme: Rising helpful advances in cancer sorts)
Cancer is a generic term for a large group of diseases that can affect any part of the body. Other terms used are malignant tumors and neoplasms. Metastases are the major cause of death from cancer. Cancer is a leading cause of death worldwide, accounting for 8.2 million deaths in 2012.
About 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred in 2008 worldwide, with 56% of the cases and 64% of the deaths in the economically developing world. Breast cancer, the most common tumour in women, presents a high survival percentage: 83% of patients have survived this type of cancer after five years. Lung cancer is one of the most aggressive tumors and survival after five years is very low: only 10% of patients diagnosed with a malignant neoplasm survive for more than five years. Colorectal cancer (of the colon and rectum), the most common malignant tumour if we group men and women together, presents an average survival rate of 50-55% five years after diagnosis, meaning that half the patients survive this form of cancer. Prostate cancer, today the most common tumour in men, has an increasingly favorable prognosis, with a global survival rate of 76%, which is higher in young adults. Ovarian cancer presents a very varied prognosis depending on age: whilst 70% of the group between 15 and 44 years survives this form of cancer, this is the case for only 19% of those over 74 years-old.
For more details please visit- http://cancer.global-summit.com/middleeast/
Importance & Scope:
Cancer is the second leading cause of death worldwide and in all regions of the world except sub-Saharan Africa. Historically, the UAE had a much lower incidence of cancer than Western countries; however, over the last 40 years, it has undergone a period of dramatic economic, social, and demographic change, resulting in increased life expectancy and prosperity.
Cancer, which is now the third leading cause of death in the UAE (after cardiovascular disease and injury) causing 10% of all deaths in 2010 and 16% of all deaths in the emirate of Abu Dhabi during the same year. The incidence of all cancers is projected to double by 2020, primarily due to ageing and also possibly due to increased exposure to risk factors for cancer. Breast cancer is the most common cancer among Emirati females (and the most prevalent cancer in both sexes combined), lung cancer is the most common cancer amongst Emirates males but is extremely rare in females, which reflects the prevalence of smoking (23.0% vs. 0.5%, respectively), and colorectal cancer is the second most common cancer.
Approximately 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred in 2008; of these, 56% of the cases and 64% of the deaths occurred in the economically developing world.
Dubai is the most populous city and emirate in the United Arab Emirates (UAE), and the second largest emirate by territorial size after the capital, Abu Dhabi and is one of the seven emirates that make up the country. Dubai recently won the bid for the World Expo 2020.
Dubai was rated as one of the best places to live in the Middle East by American global consulting firm Mercer. Dubai Creek played a vital role in the sustainment of life of the community in Dubai originally and was the setting point which caused the economic boom in Dubai. The Dubai Miracle Garden, a 72,000-square meter flower garden, opened in Dubai land. It is currently the world's largest flower garden. It has 45 million flowers with re-use of waste water through drip irrigation.
Why to attend???
Enlightening public with recent advances in Cancer diagnosis and therapy from around the world focused on cancer about recent advances in Cancer diagnosis and therapy, this is your single best opportunity to reach the largest assemblage of participants .World-renowned speakers, the most recent techniques, and the newest updates in cancer research fields are hallmarks of this conference.
Researchers, Academicians, Physicians , Post Docs, Students , Pharmacy Industries, Academic scientists ,Industry professionals ,Diagnostic laboratory professionals.
Cancer Middle East 2015 is a three day event among Global Cancer Conferences that provides a perfect platform for Researchers, Academicians, Industrial Delegates, Students, Care Givers, Oncologists and other players to share knowledge and to discuss the practical challenges encountered and the possible solutions that can be adopted for treating Cancer.
To share your views and research, please click here to register for the Conference.